Charles Greg Guyer insider trades
Open-market stock purchases and sales by Charles Greg Guyer, EVP, Chief Technical Officer at Biomarin Pharmaceutical Inc, from SEC Form 4 filings since May 4, 2020.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Mar 17, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold (not open market) | $94.9K |
| Mar 16, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Mar 16, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Mar 13, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold (not open market) | $533K |
| Mar 11, 2026 | BMRN Biomarin Pharmaceutical Inc | Sold | $997K |
| Feb 25, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Feb 25, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
| Feb 25, 2026 | BMRN Biomarin Pharmaceutical Inc | Bought (not open market) | — |
Companies traded
- BMRN Biomarin Pharmaceutical Inc: 5 sales, last Mar 17, 2026